Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-04-23-Speech-1-100"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2007-04-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Advanced therapy medicinal products (debate)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20070423.17.1-100"2
lpv:hasSubsequent	lp_eu:2007-04-23-Speech-1-1012
lpv:speaker	lp:Giles Chichester2
lpv:spoken text	". Mr President, Commissioner, first of all I should like to thank the Commissioner for his remarks about this proposal and report. I warmly support them. I should also like to state quite clearly that my committee, the Committee on Industry, Research and Energy, supports this proposal and hopes that it will go forward smoothly. So we share that objective. Next I would like to remind colleagues that the interest groups – the patient groups who are most likely to be affected by this measure and to benefit from it – strongly support the measure. I regularly see reports in the press of exciting new therapies and developments in this field, but usually they are in the USA and not in Europe, which is to our loss. I would like to congratulate the rapporteur for his work, but I have to respectfully disagree with him with regard to the two amendments from the Committee on Legal Affairs which seemed to me, and to many on my committee, to be pushing in exactly the opposite, retrogressive direction to that of this proposal. So I join in supporting the compromise package which has been put forward, particularly by my distinguished colleague Mrs Roth-Behrendt, not least because independent observers tell me that this package is in line with the ITRE Committee’s position. So naturally I support it. I am speaking for the committee, Madam; I am speaking in my turn, and you should wait for yours. I would like to remind everybody that the world around us is changing technologically, socially (although manners may not be changing), scientifically, and, as we can see in this report, biomedically. We must not deny the patients of the future the therapies of tomorrow."@en1
lpv:spokenAs	substitute; Delegation for relations with the United States (2007-03-14--2009-07-13)3 substitute; IMCO (2007-01-31--2009-07-13)3 member; ITRE (2007-01-31--2009-07-13)3 member; Conference of Delegation Chairs (2007-02-15--2008-03-26)3 member_of_the_bureau; EPP-ED (2004-08-31--2009-07-13)3 unknown; Conservative and Unionist Party (2004-07-20--2009-07-13)3 substitute; Committee of Inquiry into the crisis of the Equitable Life Assurance Society (2007-02-09--2007-06-19)3 chair; Delegation for relations with Australia and New Zealand (2007-03-14--2008-03-26)3
lpv:unclassifiedMetadata	"(Interjection from Mrs Breyer: ‘Are you speaking for the committee or on your own behalf?’)"1 "Giles Chichester (PPE-DE ),"1 "draftsman of the opinion of the Committee on Industry, Research and Energy"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph